Gapping up
In reaction to earnings/guidance:
- MP +8.2%, ALTG +5.5%, FDX +4.7%, OLLI +4.7%, LAZR +2.4%, JOBS +1.6%, ERJ +1.5%, LX +1%
Other news:
- KNSA +7.7% (announces FDA approval of ARCALYST for recurrent pericarditis)
- TNXP +7.3% (announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,946,027 to the Company on March 16, 2021)
- TRIL +5.1% (files mixed securities shelf offering)
- GPMT +4.9% (increases dividend)
- SRPT +4.2% (shares new results from ongoing study of SRP-9003)
- NCTY +4.2% (The9 Ltd's NBTC signed Bitcoin mining machine purchase agreement with Bitmain Technologies)
- AA +2.8% (announces new agreements with multiple power generators in Australia)
- WPRT +2.7% (announces co-investment agreement with Tier 1 injector manufacturing partner to expand China production footprint)
- LLNW +2.7% (announces actions to improve growth and profitability; announces workforce reduction)
- TGNA +2.5% (Standard General issues letter to the TEGNA board)
- ACM +2.2% (awarded U.S. Air Force infrastructure and facilities contract under $2 bln program)
- INCY +2.1% (announces results from Phase 3 DEVENT trial; study did not meet its primary endpoint)
- MED +1.8% (increases dividend)
- FOXA +1.4% (announces a new and expanded media rights agreement with the NFL)
Analyst comments:
- ENPH +3.9% (upgraded to Positive from Neutral at Susquehanna)
- F +3% (upgraded to Overweight from Equal Weight at Barclays)
- NAVI +2% (upgraded to Buy from Hold at Jefferies)
- EVOP +1.4% (upgraded to Buy from Neutral at Compass Point)
- KDP +1.3% (upgraded to Overweight from Neutral at JP Morgan)
- NGG +1% (upgraded to Buy from Hold at HSBC Securities)